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ycetoma is a chronic infection of the 
Msubcutaneous tissues that is caused by either a bacterial (actinomycotic) or 
fungal (eumycotic) pathogens. It presents with 
indurations and granules from discharging 
1 
sinuses. Mycetoma is restricted to the mycetoma 
belt that lie between 30°N and 15°S of the equator 
and further characterized by dry, hot climate with 
a short but heavy rainfall. Even though imported 
mycetoma can occur even outside the typical 
2mycetoma belt in any parts of the world.
Mycetoma has been recently classied among the 
neglected tropical diseases by the World Health 
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INTRODUCTION: A typical presentation of Mycetoma is not uncommon although clinical manifestations might be 
misleading leading to delay in diagnosis, treatment and consequently leading to poor prognosis. Mycetoma can have a 
fungal or bacterial etiology and manifestation is usually that of a disfiguring subcutaneous infection that can affect any part 
of the exposed body. We are reporting a case of Mycetoma in an eleven years old girl that occurred in parts of the lower 
abdomen, perineum and gluteal region that was initially thought to be a soft tissue sarcoma or disseminated tuberculosis.
CASE PRESENTATION: An eleven years old girl presented to Usmanu Danfodiyo University Teaching Hospital, Sokoto with 
lower abdominal mass and multiple nodular masses with discharging sinuses on the upper part of the right thigh, perineum 
and gluteal region of six months duration. Swellings started as multiple small boils that subsequently started discharging 
from various points. Patient usually fetches firewood in the forest for her parents as her routine house chores and she 
remembered an incident where she had pricks from thorns in the bush around her lower thigh and perineum.
On examination she was chronically ill looking, in painful distress, with bilateral inguinal lymphadenopathy. She had nodular 
lesions of varying sizes ranging from 1x1cm to 4x4cm, tender, involving the upper part of the thigh bilaterally, but more on 
the right, lower abdomen, labia and gluteal region. Some of the lesions had hyper-pigmented sinuses discharging 
mucopurulent fluid, with areas of soft tissue swelling around the lower abdomen and upper right thigh extending to the leg. 
Patient was observed to walk with a limp gait.
MANAGEMENT AND OUTCOME: An initial diagnosis of soft tissue infection to rule out soft tissue sarcoma and disseminated 
tuberculosis (abdomen and lymph nodes) and deep tissue mycosis was made. However, with further investigations and 
reviews by the medical microbiologist and anatomic pathologist, along with bacteriologic, and mycologic studies of swab 
samples and aspirate and tissue biopsy for Histology revealed an eumycotic mycetoma. She received Ketoconazole and 
Trimetoprim-sulphametoxazole. She responded significantly as lesions reduced in sizes, abdominal swelling and leg swelling 
reduced with closure of discharging sinuses. Patient could walk with some resolution of the limp. Repeat abdominal  
ultrasound scan showed resolution of initial findings. She spent four weeks in the hospital and was discharged. On 
subsequent follow-up; she was walking without any limp and lesions were healed with some scar and few areas left to dry 
up. Further follow-up visits after one month and three month showed progressive healing and complete resolution of lesion 
respectively. However. Patient was however lost to further follow-up which would have enabled monitoring as to any re-
occurrence or not. 
CONCLUSION: We presented a case of a young girl with an abnormal presentation of eumycotic mycetoma. Patient achieved 
near cure on medications without the need of surgery due to an excellent multidisciplinary approach between pediatricians, 
clinicians, clinical microbiologists and anatomic pathologists.
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Case Report
Organization with an aim of improving reportage, 
3
management and control measures.  Mycetoma 
has no vector or animal reservoir, infection is 
usually transmitted to susceptible host via 
traumatic inoculation of any of the agents into the 
4
subcutaneous tissues.  There are several genera of 
agents implicated in either the actinomycotic or the 
eumycotic form of mycetoma. The most common 
agents for the actinomycotic mycetoma are 
Nocardia asteroids, Nocardia brasiliensis, Streptomyces 
somaliensis, and Actinomadura madurae among 
others. However, the most common eumycotic 
mycetoma are Madurella mycetomatis, Madurella 
5grisea and Pseudoallescheria boydii.
Case Presentation
An eleven years old girl presented to Usmanu 
Danfodiyo University Teaching Hospital, Sokoto 
in February 2017 with complaints of lower 
abdominal mass and multiple nodular masses with 
discharging sinuses on the upper part of the right 
thigh, perineum and gluteal region of six months 
duration. The swellings started as small multiple 
boils initially, pruritic, more on the upper part of 
the right thigh but progressed over months to 
become nodular masses involving the thigh, 
perineum, gluteal region and lower abdomen and 
subsequently started discharging from various 
points. There was associated unilateral right lower 
limb swelling with limping from pain. There is 
history of weight loss but no history of street 
hawking or sexual contact. Patient usually fetches 
rewood in the forest for her parents as a routine 
house chore and she remembered an incident 
(almost three months prior to presentation) where 
she had severe pricks from thorns in the bush 
around her lower thigh and perineum while 
fetching rewood. Her parents are rural farmers 
located in a remote village of Illela local 
government area of Sokoto State bordering Nigeria 
and Niger Republic.
On examination she was ill looking, in painful 
0
distress, not pale, afebrile (36.8 C - axillary), 
anicteric, acyanosed, not dehydrated, with 
bilateral inguinal lymphadenopathy, smallest one 
measuring 1x1cm to 2cmx2cm, rm, non-tender 
with associated unilateral right lower limb 
swelling. Her weight was 25kg (70% of expected 
body weight). She had nodular lesions of varying 
sizes ranging from 1x1cm to 4x4cm, tender, 
involving the upper part of the thigh bilaterally, 
but more on the right, lower abdomen, labia and 
gluteal region. Some of the lesions had hyper-
pigmented sinuses discharging mucopurulent 
uid, with areas of soft tissue swelling around the 
lower abdomen and upper right thigh extending to 
the leg. She had a mass in the supra pubic region 
extending below the umbilicus measuring about 
8x8cm. The upper surface can be reached but the 
lower border could not be reached, rm, smooth, 
non-mobile and slightly tender. Abdominal organs 
were not palpably enlarged.
Her pulse rate was 92beats per minute and 
respiratory rate was 28 cycles per minute, blood 
pressure was 100/60mmHg. She had vesicular 
breath sounds and normal heart sounds. 
Abdominal organs were not enlarged, hymen was 
intact and neurologic examination was normal.
Management and Outcome 
Swab samples of the lesion and discharges showed 
Gram –negative bacilli, while culture yielded 
Escher ich ia  co l i  sensi t ive  to  cef tr iaxone, 
n i t r o f u r a n t o i n  a n d  T r i m e t o p r i m -
sulphamethoxazole (TMP/SMX). Abdominal 
ultrasound scan showed features in keeping with   
bladder mass and bilateral hydronephrosis and 
mesenteric lymph nodes. Retroviral screening was 
not reactive, Mantoux and genexpert were 
negative. Her packed cell volume was 32%, total 
3white cell count 17.2 X10 /uL (reference range 4-11 
3x 10 /uL), with 57.7% neutrophils and 29.4%, 
3Platelets were 559 x10 /uL. The erythrocyte 
sedimentation rate was 120mm fall/hour. 
Diagnosis of soft tissue infection was made to rule 
out soft tissue sarcoma, disseminated tuberculosis 
(abdomen and lymph nodes) and deep tissue 
mycosis. 
Further review by the medical microbiologist and 
pathologist, along with bacteriologic and 
mycologic studies of swab samples and aspirate 
and tissue biopsy for histology were done. A 
diagnosis of eumycotic mycetoma was made. 
Histology further conrmed mycetoma. She 
received intravenous antibiotics (ceftriaxone), had 
wound dressing daily,  she had minimal 
improvement and lesions did not reduce in size. 
Following the nal diagnosis of mycetoma, patient 
received ketoconazole and initial Intravenous 
antibiotics were changed to oral ciprooxacin. She 
responded signicantly as lesions reduced in sizes, 
abdominal swelling and leg swelling reduced, 
patient could walk with less limp and repeat 
abdominal ultrasound scan showed resolution of 
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initial ndings. She spent four weeks in the 
hospital and was discharged. 
On subsequent follow-up visit one weeks later, she 
was doing well on ketoconazole, oral TMP/SMX 
was added to her treatment. She was walking 
without any limp and lesions were healed with 
some scar and few areas left to dry up. Further 
follow-up visits after one month and three month 
showed patient has done very well and all lesions 
were healed. Unfortunately, patient was lost to 
follow up after three months and efforts to trace her 
further assessment were unsuccessful. 
Figure 3: One week after treatment, lesions started resolving 
and swelling subsided
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Figure 1: Patients condition at presentation with nodular 
lesions (circle blue) and discharging sinuses (red circle)
Figure 2: Unilateral leg swelling and discharging 
sinuses at presentation
Figure 4:  Section show acanthotic skin (black arrow), with 
lympho-plasma cell including eosinophils inltrate.  
Amorphous to lamentous eosinophilic to basophilic 
materials that is consistent with colony of bacteria / fungi are 
noted (white arrow). H and E X 100
DISCUSSION
Despite the chronic disguring ailments with the 
attendant social stigma caused by mycetoma it 
was not until recently that the disease was 
included in the list of neglected tropical diseases. 
Even at that, the WHO is yet to issue guideline for 
treatment, reporting or prevention of this 
3condition.
Epidemiologic studies have elucidated that 
mycetoma is commonly a disease affecting young 
adults, males from an agrarian background 
3 resident of endemic areas. Our index patient is a 
young female from a family of farmers. Her sex 
and age offer her no social protection from being 
exposed to the agents due to mostly demands of 
her family. Even though, the lower incidence of 
mycetoma among female was initially attributed 
3
to the possible protective effect of progesterone  
but this was debunked later since mycetoma was 
4
found to be more aggressive during pregnancy.  
Greater emphasis is now placed on higher physical 
3
activities rather than hormonal factors.
Our patient could remember a day that she had a 
thorn prick around her abdomen and perineum 
while fetching rewood at least three months prior 
to presentation. This is in line with the known 
transmission pathway for mycetoma by available 
literature where the infective agent from soil or 
animal dung gain access to the subcutaneous 
tissue following traumatic inoculation after 
6
piercing the skin by thorn usually.
One of the bad prognostic factors that worsens 
339
patient's outcome is delay in seeking treatment due 
to the slow painless progression of the lesion 
caused by mycetoma. This was not the case for the 
index patient as she reported early enough (six 
3 months) after infection. This is a good timing when 
compared with a case of a patient from Senegal 
who presented 15 years after primary infection 
7
with complicated mycetoma.
Normally, mycetoma presents on body parts 
exposed to the outside environment. Commonest 
sites are the foot followed by hand while the head, 
neck, abdominal walls, perineum are hardly 
8, 9
affected.  Our patient presented with an atypical 
presentation of mycetoma in the lower abdomen, 
perineum and gluteal region outside the normal 
sites and could have easily been misdiagnosed if 
not for the excellent multi-disciplinary practice 
and collaboration amongst physicians in our 
institution.  
Eumycotic mycetoma was formerly treated by 
amputation or multiple excisions alone. However, 
medical management with antifungal agents is 
now strongly advocated especially for cases that 
10, 11 
present early. Our index patient was managed 
successfully with ketoconazole without the need of 
surgery despite the case being an eumycotic 
mycetoma probably because of the patient's early 
presentation. Zein et al attributed patients' drop 
out of follow-up visits to either treatment failure or 
12
complete resolution of lesion.  Unfortunately, our 
patient was lost to follow up after six months and 
efforts to trace her were unsuccessful. Likely 
reason for her being lost to follow up is due to good 
clinical outcome as her previous visits showed that 
patient has done very well, and all lesions were 
healed. 
CONCLUSION
We bring to fore an abnormal presentation of 
eumycotic mycetoma. Patient presented early and 
had diagnosis made on time with commencement 
of appropriate medication due to the excellent 
multidisciplinary collaborations among clinicians 
and pathologists. Patient achieved near cure on 
medications without the need of surgery.
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